Yahoo19d
"Battle Of The Badges" Blood Drive
36,279 people played the daily Crossword recently. Can you solve it faster than others?36,279 people played the daily Crossword recently. Can you solve it faster than others?
Yahoo19d
U of I Police officer awarded Badge 1 honor
38,858 people played the daily Crossword recently. Can you solve it faster than others?38,858 people played the daily Crossword recently. Can you solve it faster than others? Hunter Schafer’s ...
News & Record19d
Eden Police Department says goodbye to one officer and welcomes next generation
Sgt. John Roberts was recognized for making the Most Drug Arrests of any officer on the force, 62 of more than 600 drug arrests for the Eden Police Department for the year 2024. “In 2023 ...
TMCnet20d
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
pediatric plaque psoriasis and pediatric psoriatic arthritis. This is the second biosimilar now available in the U.S. market under the Teva and Alvotech strategic partnership. The FDA has ...
Nasdaq20d
Teva Pharmaceuticals and Alvotech Announce FDA Approval of SELARSDI™ Biosimilar for Multiple Indications
pediatric plaque psoriasis and pediatric psoriatic arthritis. This is the second biosimilar now available in the U.S. market under the Teva and Alvotech strategic partnership. The FDA has ...
Nasdaq20d
Teva Pharmaceuticals and Alvotech Announce U.S. Launch of SELARSDI™ Biosimilar for Autoimmune Diseases
The U.S. Food and Drug Administration (FDA) has approved SELARSDI™ (ustekinumab-aekn), a biosimilar to Stelara® (ustekinumab), for treating various conditions including plaque psoriasis ...
Yahoo Finance20d
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
pediatric plaque psoriasis and pediatric psoriatic arthritis. This is the second biosimilar now available in the U.S. market under the Teva and Alvotech strategic partnership. The FDA has ...
Pharmabiz22d
New research highlights the role of aspirin and advanced ultrasound techniques in cardiovascular health
This approach involves balancing the potential benefits of aspirin in reducing CV events against the risks of bleeding, using tools like coronary artery calcium (CAC) scoring and carotid plaque scores ...
Pharmabiz23d
Bristol Myers Squibb announces positive data from POETYK PSO LTE trial of Sotyktu to treat moderate-to-severe plaque psoriasis
Bristol Myers Squibb announced new five-year results from the POETYK PSO long-term extension (LTE) trial of Sotyktu (deucravacitinib) treatment in adult patients with moderate-to-severe plaque ...
Orange County Register24d
Trump administration cuts reach FDA employees in food safety, medical devices and tobacco products
WASHINGTON (AP) — The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this weekend, as recently hired employees who review the ...
Medscape26d
In the Pipeline: FDA Advisory Committee Reviews
Subject: BLA 125075: Raptiva (efalizumab), Genentech Inc., for the proposed treatment of adult patients with moderate to severe plaque psoriasis ... stop the study drug. Of over 2,700 psoriasis ...